HomeELTP • OTCMKTS
add
Elite Pharmaceuticals, Inc. Common Stock
Previous close
$0.13
Day range
$0.12 - $0.14
Year range
$0.030 - $0.21
Market cap
138.01M USD
Avg Volume
519.30K
P/E ratio
8.89
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 15.54M | 67.99% |
Operating expense | 3.51M | 18.52% |
Net income | 706.35K | -76.22% |
Net profit margin | 4.55 | -85.83% |
Earnings per share | — | — |
EBITDA | 3.87M | 70.21% |
Effective tax rate | 849.38% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.82M | -67.52% |
Total assets | 74.70M | 41.70% |
Total liabilities | 28.28M | 25.47% |
Total equity | 46.41M | — |
Shares outstanding | 1.02B | — |
Price to book | 2.52 | — |
Return on assets | 12.15% | — |
Return on capital | 16.50% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 706.35K | -76.22% |
Cash from operations | -2.40M | -321.88% |
Cash from investing | -406.01K | -57,003.66% |
Cash from financing | -30.65K | 60.38% |
Net change in cash | -2.83M | -338.49% |
Free cash flow | -3.14M | -47.07% |
About
Founded
1997
Headquarters
Website
Employees
53